NSPR
InspireMD, Inc.
NASDAQ · Healthcare · Medical - Devices · IL
$0.85
+1.26%Year over year
Reported trailing growth
- Revenue
- +53.4%
- EBITDA
- +9.1%
- EBIT
- -26.6%
- EPS
- +40.2%
- Free cash flow
- -35.9%
- Operating cash flow
- -39.3%
Forward estimates
Based on analyst estimates
- Revenue
- +9.2%
- EBITDA
- +7.2%
- EPS
- +1.6%
Three-year CAGR
- Revenue
- +20.2%
- EBITDA
- -52.4%
- EBIT
- -46.6%
- Net income
- -52.4%
- EPS
- +0.0%
- Free cash flow
- -58.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026